Atypical hyperplasia of the breast--risk assessment and management options

N Engl J Med. 2015 Jan 1;372(1):78-89. doi: 10.1056/NEJMsr1407164.

Authors

Lynn C Hartmann¹, Amy C Degnim, Richard J Santen, William D Dupont, Karthik Ghosh

Affiliation

¹ From the Departments of Oncology (L.C.H.), Surgery (A.C.D.), and Internal Medicine (K.G.), Mayo Clinic, Rochester, MN; the Department of Endocrinology and Metabolism Medicine, University of Virginia, Charlottesville (R.J.S.); and the Department of Biostatistics, Vanderbilt University, Nashville (W.D.D.).

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Biopsy
Breast / pathology*
Breast Neoplasms / pathology*
Breast Neoplasms / prevention & control
Female
Humans
Hyperplasia / pathology
Hyperplasia / therapy
Incidence
Magnetic Resonance Imaging
Mastectomy
Middle Aged
Risk Assessment*
Selective Estrogen Receptor Modulators / therapeutic use

Substances

Selective Estrogen Receptor Modulators

Grants and funding